Strepsils Intensive, for acute sore throat, 16 lozenges

Strepsils Intensive is a strong analgesic and anti-inflammatory drug in the form of lozenges, used for the short-term symptomatic treatment of sore throat.

Strepsils Intensive tablets contain flurbiprofen , which:

• works on the main cause of sore throat – inflammation,
• penetrates deep into the layers of throat tissue,
• relieves symptoms of inflammation such as: pain, difficulty swallowing, throat swelling,
• Soothes and relieves pain in just two minutes after application.

The drug is recommended for ailments caused by both viruses and bacteria.

Strepsils Intensive is indicated for the short-term symptomatic treatment of sore throat in adults and children from 12 years of age.

1 Strepsils Intensive lozenge contains the active substance: flurbiprofen and excipients: macrogol 300, potassium hydroxide, lemon flavour, levomenthol, glucose syrup, sucrose syrup, honey.

• Side effects can be minimized by using the lowest effective dose for the shortest period necessary to relieve symptoms. Treatment with Strepsils Intensive should not last longer than 3 days.
• Strepsils Intensive is intended for adults and children over 12 years of age.
• Recommended dose: One lozenge every 3 to 6 hours as needed.
• The tablet should be sucked slowly. The position of the tablet in the mouth should be changed while sucking to avoid local irritation.
• Do not use more than 5 lozenges per day.
• The drug starts working after just 2 minutes.

Strepsils Intensive should be used as directed. If in doubt, consult your doctor or pharmacist.

• if you are allergic to flurbiprofen, acetylsalicylic acid, other nonsteroidal anti-inflammatory drugs (NSAIDs) or any of the other ingredients of this medicine;
• in patients with existing or previous gastric and/or duodenal ulcer, with severe colitis;
• in patients who have ever had allergy symptoms such as runny nose, angioedema, difficulty breathing (bronchial asthma), rash after taking acetylsalicylic acid or any non-steroidal anti-inflammatory drug;
• in patients with a history of gastrointestinal bleeding or perforation, bleeding disorders or blood formation disorders related to previous NSAID therapy;
• in patients taking other non-steroidal anti-inflammatory drugs at the same time (including cyclooxygenase-2 inhibitors such as celecoxib);
• in patients in the third trimester of pregnancy;
• in patients with severe heart, liver or kidney failure.